{"timestamp": 1771603030.24233, "value": {"ticker": "ASBP", "company_name": "Aspire Biopharma Holdings, Inc.", "short_name": "Aspire Biopharma Holdings, Inc.", "sector": "Healthcare", "industry": "Biotechnology", "country": "United States", "market_cap": 6993400, "float_shares": 2331905, "shares_outstanding": 4790000, "short_ratio": 0.37, "short_percent_of_float": 0.1649, "shares_short": 693745, "shares_short_prior": 278737, "insider_percent_held": 0.108380005, "institution_percent_held": 0.048520003, "total_cash": 1948271, "total_debt": 8624743, "total_revenue": 1941, "revenue_growth": 0, "earnings_growth": 0, "profit_margins": 0.0, "gross_margins": 0.45543998, "operating_margins": -590.15814, "debt_to_equity": 0, "current_ratio": 0.173, "book_value": -9.262, "price_to_book": -0.15763335, "operating_cashflow": -3516078, "free_cashflow": 16946968, "price": 1.46, "52w_high": 394.4, "52w_low": 1.2, "avg_volume": 1194577, "avg_volume_10d": 1290680, "full_time_employees": 0, "audit_risk": 0, "overall_risk": 0}}